Karyopharm Therapeutics competitors

Karyopharm Therapeutics Competitors include Replimune, Galectin Therapeutics, Pharmacyclics and Stemline Therapeutics.
Add company...
Karyopharm Therapeutics
Karyopharm Therapeutics
Karyopharm Therapeutics is a clinical-stage pharmaceutical company developing drugs for the treatment of cancer and other major diseases.
Replimune
Replimune
Replimune Ltd. develops oncolytic immunotherapies for the treatment of cancer.
Galectin Therapeutics
Galectin Therapeutics
Galectin Therapeutics uses galectin science and drug development to create new therapies for fibrotic diseases and cancer.
Pharmacyclics
Pharmacyclics
Pharmacyclics Inc. is a clinical-stage biopharmaceutical company focused on discovering and developing innovative small-molecule drugs for the treatment of cancer and immune mediated diseases.
Stemline Therapeutics
Stemline Therapeutics
Stemline Therapeutics is a clinical stage biopharmaceutical company developing oncology compounds that target cancer stem cells.
Founding Date
Founding Date
2008
Founding Date
2015
Founding Date
2001
Founding Date
1991
Founding Date
2003
Type
Type
Subsidiary
Type
Public
Type
Public
Type
Subsidiary
Type
Public
Tags
Locations
Locations
Newton, US HQ
München, DE
Locations
Milton, GB HQ
Woburn, US
Locations
Norcross, US HQ
Locations
Sunnyvale, US HQ
Shanghai, CN
Schaffhausen, CH
South San Francisco, US
Locations
New York, US HQ
Employees
Employees
N/A
Employees
N/A
Employees
7
Employees
N/A
Employees
327% increase
Valuation ($)
Valuation ($)
N/A
Valuation ($)
N/A
Valuation ($)
205.3 m
Valuation ($)
N/A
Valuation ($)
329.5 m
Twitter followers
Twitter followers
N/A
Twitter followers
N/A
Twitter followers
487
Twitter followers
840
Twitter followers
N/A

Financial

Net income
Net income
($129m) (FY, 2017)
Net income
(£8.2m) (FY, 2018)
Net income
($16.2m) (FY, 2017)
Net income
$86.1m (FY, 2014)
Net income
($67.8m) (FY, 2017)

Funding

Total funding raised
Total funding raised
$ 248.7m
Total funding raised
$ 30m
Total funding raised
N/A
Total funding raised
N/A
Total funding raised
N/A
For sources of this data, please see the company profileDownload Excel

View company profiles

Replimune
HQ
Milton, GB

Replimune Ltd. develops oncolytic immunotherapies for the treatment of cancer.

View company
Galectin Therapeutics
HQ
Norcross, US
Employees
7

Galectin Therapeutics uses galectin science and drug development to create new therapies for fibrotic diseases and cancer.

View company
Pharmacyclics
HQ
Sunnyvale, US

Pharmacyclics Inc. is a clinical-stage biopharmaceutical company focused on discovering and developing innovative small-molecule drugs for the treatment of cancer and immune mediated diseases.

View company
Stemline Therapeutics
HQ
New York, US
Employees
32↑ 7% increase

Stemline Therapeutics is a clinical stage biopharmaceutical company developing oncology compounds that target cancer stem cells.

View company